Search results
COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
AOL· 7 hours agoThe U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update their formulas for fall doses, in an attempt to target ...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks via Yahoo Finance· 12 hours agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved...
New COVID-19 strain KP.3 circulating in US. What is the situation in Riverside County?
The Desert Sun· 16 hours agoA new COVID-19 variant called KP.3 is on the rise in the United States and has been detected in...
Moderna's (MRNA) Next-Gen COVID-19 Jab Study Meets Efficacy Goal
Zacks· 13 hours agoData from a late-stage study shows that Moderna's (MRNA) next-generation COVID-19 vaccine achieved non-inferior vaccine efficacy against ...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News via Yahoo News· 5 days agoModerna, which is developing a combination COVID-flu vaccine, announced on Monday that in phase 3...
Moderna’s combo COVID and flu vaccine works better than stand-alone shots on the market, study finds
Market Watch· 5 days agoexperimental combination COVID and flu vaccine triggered better immune responses than stand-alone...
Another COVID vaccine? Yes, and here’s why
Denver Post· 4 days agoVaccine manufacturers Pfizer and Moderna say they were prepared to make updated vaccines available in August, pending final FDA approval ...
Is It Too Late to Buy Pfizer Stock?
The Motley Fool via AOL· 1 day agoTo make matters worse, the forces behind this purported decline do not imply room for recovery. As shown on the chart, Pfizer's performance during the...
The FDA Could, Finally, Approve Novavax's Covid Vaccine — Is Novavax Stock A Buy?
Investor's Business Daily· 2 days agoNovavax will also receive tiered royalties on sales. Sanofi also made a $70 million investment in...
FDA asks COVID vaccine makers to target KP.2 strain, if feasible, for next shot
Reuters via Yahoo News· 24 hours agoThe Food and Drug Administration's change in recommendation, in an update dated Thursday, comes even...
